{
    "code": 0,
    "data": [
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9521c78f-7cfe-4c1e-b465-a3634cc30df5.pdf",
            "news_date": "2026-02-09 15:01:47"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of the investor conference call for Q3 & 9M FY26 held on February 3 2026.",
            "news_id": "ba0b4eff-6425-488f-bed4-7a565f2515ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49858517-2821-4378-ab5b-bee857346a00.pdf",
            "news_date": "2026-02-09 13:37:43",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith the transcript of the investor conference call for Q3 & 9M FY26 held on February 3 2026.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49858517-2821-4378-ab5b-bee857346a00.pdf",
            "news_date": "2026-02-09 13:37:43"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached intimation regarding newspaper advertisement - Unaudited Financial Results of the Company for Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8340728-4dd5-4607-8a83-a0620e282eb8.pdf",
            "news_date": "2026-02-04 14:09:06"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation of participation in Investor Conference",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=666b1ce3-8aec-4074-9f11-43e3e624c210.pdf",
            "news_date": "2026-02-04 13:45:41"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q3 & 9M FY26",
            "news_id": "30d0011c-f58f-431f-b8e2-53768c6a7160",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4eaabab0-76f0-465a-b532-c0cf52275450.pdf",
            "news_date": "2026-02-03 21:53:40",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q3 & 9M FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4eaabab0-76f0-465a-b532-c0cf52275450.pdf",
            "news_date": "2026-02-03 21:53:40"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 54 - Asset Cover details",
            "caption": "Compliances-Reg. 54 - Asset Cover details ",
            "news_body": "Compliance Certificate under Regulation 54 of SEBI LODR for Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dad294ad-313f-4fc6-8e00-dd6bafab9b42.pdf",
            "news_date": "2026-02-03 16:25:39"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q3 FY26 for financial results",
            "news_id": "9b3e476f-253c-40f3-9287-6e64fd5e605f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa7f58c8-bb30-43c8-8184-df124142ee0b.pdf",
            "news_date": "2026-02-03 16:21:57",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q3 FY26 for financial results",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fa7f58c8-bb30-43c8-8184-df124142ee0b.pdf",
            "news_date": "2026-02-03 16:21:57"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release for Q3 FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=320e5cae-9111-4fee-98c9-dfab0a12aa7f.pdf",
            "news_date": "2026-02-03 16:20:07"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Of Financial Results For Q3 FY26",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b306b769-b407-46a2-9eaf-1843c55053fc.pdf",
            "news_date": "2026-02-03 16:18:23"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Result For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Please find attached the Unaudited Financial Results for the quarter and nine months ended December 31 2025",
            "news_id": "25cb75c5-d312-48cd-a3f2-9709e6610ae7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86b2b3ea-b33a-4bb0-9c64-b6298be2e468.pdf",
            "news_date": "2026-02-03 16:14:32",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Result For The Quarter And Nine Months Ended December 31 2025",
            "news_body": "Please find attached the Unaudited Financial Results for the quarter and nine months ended December 31 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=86b2b3ea-b33a-4bb0-9c64-b6298be2e468.pdf",
            "news_date": "2026-02-03 16:14:32"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Please find attached Intimation regarding withdrawal and outstanding Credit Ratings granted by ICRA Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c0cd1cfd-1c70-406f-a410-4d11bf83430a.pdf",
            "news_date": "2026-01-16 18:27:22"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation regarding Investor Conference Call for Q3 & 9M FY26 with Senior Management",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e8d2ef9b-4bdf-4594-8b1d-c19d6e6c1b6d.pdf",
            "news_date": "2026-01-16 15:22:35"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company",
            "news_body": "Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2026 inter alia to consider and approve approval of unaudited standalone and consolidated financial results of the company for the quarter and nine months ended on December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=159502be-f73a-41e7-9089-1a416609a7ad.pdf",
            "news_date": "2026-01-09 11:53:21"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018 for the quarter ended December 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ec4c3865-d74d-4152-9649-4cc1bb6c20f5.pdf",
            "news_date": "2026-01-05 16:06:03"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find attached intimation regarding Closure of the Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dcc7d829-f210-41c5-8b7d-cf6d72a72598.pdf",
            "news_date": "2025-12-24 13:34:37"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find attached intimation regarding Closure of the Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8a381547-4aad-43b9-bdde-5ff563420363.pdf",
            "news_date": "2025-12-24 13:34:01"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 (Listing Regulations)",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d0f88ca-6e45-4423-8688-82a5c79358e2.pdf",
            "news_date": "2025-12-10 18:27:32"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding ESG Rating",
            "news_body": "Please find attached intimation regard ESG rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2a0a01c5-f213-492b-af9a-47c2959c5e2e.pdf",
            "news_date": "2025-12-10 13:47:05"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding ESG Rating",
            "news_body": "Please find attached intimation regarding ESG Rating assigned by SES ESG Research Private Limited.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4a676a81-3aef-4e6a-a229-430c7b0850aa.pdf",
            "news_date": "2025-11-28 16:38:36"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of Equity Shares",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment",
            "news_body": "Please find attached intimation regarding allotment of 46582 equity shares pursuant to Mankind Employee Stock Option Plan 2022",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c142817d-9d75-44d5-be81-38a9d49ee3f4.pdf",
            "news_date": "2025-11-26 16:36:40"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=509408cd-fa43-4a63-8c21-0c51a5b5cef1.pdf",
            "news_date": "2025-11-16 15:13:47"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Please find attached Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06fcc2e0-a731-48e0-bea0-01641b12c8ca.pdf",
            "news_date": "2025-11-15 14:19:48"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Please find attached Intimation regarding Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2ce64ccd-7489-4509-ace0-da7d3b4602c1.pdf",
            "news_date": "2025-11-13 21:29:53"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation of participation in Investor Conference",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f64df838-8158-452a-8746-6e16a8e4aada.pdf",
            "news_date": "2025-11-13 10:38:14"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the investor Conference Call for Q2 & H1 FY 26",
            "news_id": "7df9e816-0071-4ebb-a634-0430b9ed2bd4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09896907-dd89-468c-869d-25ae30374415.pdf",
            "news_date": "2025-11-11 17:49:48",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the investor Conference Call for Q2 & H1 FY 26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09896907-dd89-468c-869d-25ae30374415.pdf",
            "news_date": "2025-11-11 17:49:48"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation for participation in the Investor Conference.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5307941b-a4a7-41b9-9ee5-6e42d7fa2009.pdf",
            "news_date": "2025-11-07 15:02:58"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached intimation regarding newspaper advertisement-unaudited financial results of the Company for Q2H1FY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72eefb2f-58ce-4555-bc44-b861afd8afe8.pdf",
            "news_date": "2025-11-07 11:46:01"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q2H1FY26",
            "news_id": "4cbea6fc-a40c-4026-96ef-cbd1748d797d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c33b4f6-3848-4e7e-8dc8-dcca5865bb30.pdf",
            "news_date": "2025-11-06 20:00:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Please find attached intimation containing link of the Audio Recording-Investor Conference Call for Q2H1FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0c33b4f6-3848-4e7e-8dc8-dcca5865bb30.pdf",
            "news_date": "2025-11-06 20:00:11"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Financial Results for the quarter and half year ended 30th September 2025",
            "news_id": "a430f5a9-0f8f-499b-8e59-a51accee2ee1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=740ea2bd-a613-4c62-b450-70ab75a552ed.pdf",
            "news_date": "2025-11-06 16:38:44",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended 30Th September 2025",
            "news_body": "Financial Results for the quarter and half year ended 30th September 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=740ea2bd-a613-4c62-b450-70ab75a552ed.pdf",
            "news_date": "2025-11-06 16:38:44"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release for Q2FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e66aca0b-b48e-4d69-93cf-178199eb24fc.pdf",
            "news_date": "2025-11-06 16:32:30"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2FY26",
            "news_id": "35772d03-89be-469f-ae60-90a64e5f6814",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7951849a-2f16-43f2-a94b-a1740f7d2ca1.pdf",
            "news_date": "2025-11-06 16:30:39",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q2FY26",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7951849a-2f16-43f2-a94b-a1740f7d2ca1.pdf",
            "news_date": "2025-11-06 16:30:39"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting",
            "news_body": "Un-audited Financial Results for the Quarter and Half Year ended 30.09.2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=04f4f99f-bb27-4a28-949e-ba5cf9c96343.pdf",
            "news_date": "2025-11-06 16:29:03"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding ESG Rating",
            "news_body": "Please find attached intimation of ESG Rating assigned by MSCI",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7011df8c-1749-4e2f-a5a3-1de473486b49.pdf",
            "news_date": "2025-11-04 22:51:53"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding ESG Rating",
            "news_body": "Please find attached ESG Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e22e629-fe66-4bc0-93f4-583dfc5ddbe1.pdf",
            "news_date": "2025-10-29 22:16:49"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Credit Rating",
            "caption": "Announcement under Regulation 30 (LODR)-Credit Rating",
            "news_body": "Please find attached intimation regarding withdrawal/reaffirmation of Credit Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09359a83-625b-4024-8e0c-c0bebc980cd9.pdf",
            "news_date": "2025-10-29 18:06:47"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation of Investor Conference Call for Q2 & H1 FY26 with Senior Management of Mankind Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9a42043-8cdc-498a-becb-a42aea8de432.pdf",
            "news_date": "2025-10-29 10:42:22"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended On September 30 2025",
            "news_body": "Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and half year ended on September 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9aaa8a91-c5de-4c33-918f-8025670e4878.pdf",
            "news_date": "2025-10-27 18:24:28"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Please find attached updated on acquisition-Execution of Business Transfer Agreement between Mankind Pharma Limited and Bharat Serums & Vaccines Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=76c1197f-7df8-45b1-aa03-059ed80cfa93.pdf",
            "news_date": "2025-10-10 16:27:26"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Please find attached Certificate under Reg. 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c85bd07-a8c2-499a-be2a-5d0868341006.pdf",
            "news_date": "2025-10-04 22:14:17"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Please find attached intimation of closure of trading window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=baf4fb01-c5e7-420b-935c-3bce1e8c9d60.pdf",
            "news_date": "2025-09-25 18:05:17"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation of participation in Investor Conference by management of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58e7a454-c9f5-4be1-b507-0b82990b892d.pdf",
            "news_date": "2025-09-15 17:01:55"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5037ebf-dcb3-4371-ad8b-e51b6465b976.pdf",
            "news_date": "2025-09-10 22:33:07"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation of participation in Investor Conference by management of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa6f0295-fe0b-4ade-8e6c-75dd102550a9.pdf",
            "news_date": "2025-09-09 12:26:35"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Receipt Of Approval For Reclassification",
            "news_body": "Please find attached intimation of receipt of approval for reclassification of Ayushi and Poonam Estates LLP from \"Promoter & Promoter Group\" to \"Public\" Category",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=40ea50a2-9ac2-472c-bc2d-0daaeeb7b431.pdf",
            "news_date": "2025-09-02 18:08:57"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation of participation in Investor Conference",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89ac989f-1db9-4edb-8043-fa8244a4df0e.pdf",
            "news_date": "2025-08-27 15:38:19"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of 29742 Equity Shares under Mankind Employee Stock Option Plan 2022",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=25cddbee-fd92-4876-aa37-6629778201db.pdf",
            "news_date": "2025-08-26 14:34:12"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Please find attached intimation of participation in Investor Conference",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10259aad-5114-40de-90d9-5cab3c5a38da.pdf",
            "news_date": "2025-08-25 17:41:28"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Regarding ESG Rating",
            "news_body": "Please find attached intimation under Regulation 30 & 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015-Environmental Social and Governance Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bdad0a9f-a0a2-4b4f-93a6-221c10fef172.pdf",
            "news_date": "2025-08-22 23:00:18"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Please find attached intimation regarding incorporation of a wholly owned subsidiary in Russia",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=29792a03-6e5c-43ae-8bdf-adb6ed26989c.pdf",
            "news_date": "2025-08-19 15:14:05"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation about the upcoming Investor Meet of Mankind Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d016e1b4-abbc-43f4-936f-8a98a2964792.pdf",
            "news_date": "2025-08-11 17:27:04"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "We wish to inform you that the shareholders of the Company at the 34th Annual General Meeting held on Thursday August 7 2025 has considered and approved the appointment of M/s. Amit Gupta & Associates as Secretarial Auditors of the Company. Said appointment was earlier considered and approved by the Board of Directors of the Company in its meeting held on May 21 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4479c3e7-d38c-4ffc-9041-8c70f7bffc8b.pdf",
            "news_date": "2025-08-08 17:46:40"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report",
            "news_body": "Please find enclosed herewith voting results and Scrutinizers Report pertaining to 34th Annual General Meeting of the Company held on August 7 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce99bbdc-b14f-402e-be59-89293a71aae8.pdf",
            "news_date": "2025-08-08 16:43:30"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "AGM",
            "caption": "Shareholder Meeting / Postal Ballot-Outcome of AGM",
            "news_body": "Please find enclosed herewith proceedings of the 34th Annual General Meeting of the Company held on August 7 2025 through Video Conferencing.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=328a9811-b44c-457c-af2d-175943150183.pdf",
            "news_date": "2025-08-07 17:39:24"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the Investor Conference Call for Q1 FY26 held on August 1 2025",
            "news_id": "b1209c74-ca53-4689-969b-d91e99c15d04",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c81dfdb-7723-4f42-a476-4753e4c7086b.pdf",
            "news_date": "2025-08-06 23:20:46",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Please find enclosed herewith transcript of the Investor Conference Call for Q1 FY26 held on August 1 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c81dfdb-7723-4f42-a476-4753e4c7086b.pdf",
            "news_date": "2025-08-06 23:20:46"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation For Submission Of Application For Reclassification",
            "news_body": "We wish to inform you that the Company has today i.e. August 3 2025 submitted application for reclassification of Ayushi and Poonam Estates LLP from the \"Promoter and Promoter Group\" Category to \"Public\" Category.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8176f680-8775-46fa-8cad-b10aefc14665.pdf",
            "news_date": "2025-08-03 22:32:46"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Please find attached Newspaper Publication of unaudited financial results for the quarter ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1b9614ad-d2e7-4d6f-9b28-3896f309457d.pdf",
            "news_date": "2025-08-01 17:03:38"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q1 & FY26 - Audio Recording",
            "news_id": "42809223-c415-4f25-86a5-031bd1c62699",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71c3a3ab-2448-4ed0-935e-1b9701933035.pdf",
            "news_date": "2025-08-01 15:06:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q1 & FY26 - Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=71c3a3ab-2448-4ed0-935e-1b9701933035.pdf",
            "news_date": "2025-08-01 15:06:11"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Announcement Under Regulation 30- TDS Communication To The Shareholders.",
            "news_body": "Please find attached the Specimen of the Communication sent to the shareholders regarding the deduction of tax to be deducted on the Interim Dividend declared by the Board of Directors for FY 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=08f47cc8-3c56-4b88-86a3-6aeca122c83b.pdf",
            "news_date": "2025-07-31 21:56:24"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Monitoring Agency Report",
            "caption": "Announcement under Regulation 30 (LODR)-Monitoring Agency Report",
            "news_body": "Please find attached Monitoring Agency Report as issued by Care Ratings Limited for the quarter ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2042d725-0113-4ffb-9572-399e00e94fde.pdf",
            "news_date": "2025-07-31 18:54:26"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Change in Management",
            "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
            "news_body": "Dr. Sanjay Koul has tendered his resignation from the position of Chief Marketing Officer of the Company w.e.f. August 1 2025. Further Mr. Koul will also cease to be a Senior Management Personnel of the Company with effect from aforesaid date.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46349e16-3628-485a-a591-26571ab190cd.pdf",
            "news_date": "2025-07-31 18:39:44"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Restructuring",
            "caption": "Announcement under Regulation 30 (LODR)-Restructuring",
            "news_body": "Board of Directors of the Company in its meeting held on July 31 2025 has considered and approved the acquisition of Branded Generic Business relating to Women Health Rx Portfolio of Bharat Serums and Vaccines Limited a wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3084dc6-f1ab-4a02-b252-56cfb70596c8.pdf",
            "news_date": "2025-07-31 18:27:09"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Board of Directors of the Company in its meeting held on July 31 2025 has considered and approved the acquisition of Branded Generic Business relating to Women Health Rx Portfolio of Bharat Serums and Vaccines Limited a wholly owned subsidiary of the Company.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=65c124a7-5791-4567-86b6-e2b12bafe3bf.pdf",
            "news_date": "2025-07-31 18:17:34"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Record Date",
            "caption": "Intimation Of Record Date",
            "news_body": "Board of Directors of the Company in its meeting held on July 31 2025 has fixed Friday August 8 2025 as the record date for purpose of ascertaining the eligibility of shareholders for payment of interim dividend.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f359cfb-7b48-4337-9ab3-0e6f6e02bf76.pdf",
            "news_date": "2025-07-31 18:11:35"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board approves Dividend",
            "news_body": "Board of directors of the Company in its meeting held on July 31 2025 has considered and approved the payment of interim dividend of Rs. 1/- per equity share",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8fd7fafd-3cb8-45dc-a423-4d8beeababd1.pdf",
            "news_date": "2025-07-31 18:06:04"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Please find attached press release",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a8606bfa-37e8-4b61-8ad1-61b30e019c99.pdf",
            "news_date": "2025-07-31 17:59:44"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached Investor Presentation",
            "news_id": "30360094-d2ed-4317-8340-a89d62e3c20c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9390a370-5720-4b96-8d2c-d1065a2ab458.pdf",
            "news_date": "2025-07-31 17:54:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Please find attached Investor Presentation",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9390a370-5720-4b96-8d2c-d1065a2ab458.pdf",
            "news_date": "2025-07-31 17:54:11"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended On June 30 2025",
            "news_body": "Please find attached un-audited financial results for the quarter ended on June 30 2025",
            "news_id": "a42f129a-129f-4180-ba39-ccc0ad311ec5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2571e45e-4fa5-4ba5-8739-771a36c4ba7e.pdf",
            "news_date": "2025-07-31 17:50:01",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Un-Audited Financial Results For The Quarter Ended On June 30 2025",
            "news_body": "Please find attached un-audited financial results for the quarter ended on June 30 2025",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2571e45e-4fa5-4ba5-8739-771a36c4ba7e.pdf",
            "news_date": "2025-07-31 17:50:01"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Outcome of Board Meeting",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held On July 31 2025",
            "news_body": "Outcome of Board Meeting held on July 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97c52b18-fad1-4238-a994-646790d5093d.pdf",
            "news_date": "2025-07-31 17:05:31"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Updates on Acquisition",
            "news_body": "Intimation of incorporation of a wholly owned subsidiary company in Sri Lanka",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dffdefd1-67cf-43a9-8d3f-113a4b5eb5cb.pdf",
            "news_date": "2025-07-24 17:52:26"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Of Receipt Of Request For Reclassification",
            "news_body": "Intimation of receipt of request from M/s. Ayushi and Poonam Estates LLP for reclassification of shareholding from \"Promoter and Promoter Group\" Category to \"Public\" Category.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55031a9f-192a-4b81-9d51-74a9e39ec4dc.pdf",
            "news_date": "2025-07-22 17:47:34"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Pursuant to Regulation 30 and 51 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we hereby inform you that the Company will host Investor Conference Call on Friday August 01 2025 at 12:00 noon (IST) for Q1 FY26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b4aa98b-34ee-436c-bd23-3bbc8d345c7f.pdf",
            "news_date": "2025-07-18 16:57:27"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "AGM",
            "caption": "Intimation Of Dispatch Of Letter To Shareholders Whose E-Mail Addresses Are Not Registered With Company Or Depositories",
            "news_body": "Intimation of dispatch of Letter to Shareholder whose e-mail addresses are not registered with Company or Depositories",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=98ed7549-0ce4-4837-a465-544ada22897a.pdf",
            "news_date": "2025-07-17 17:18:06"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Advertisement for Intimation of 34th AGM and related information of Mankind Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f0739360-3b27-49fe-ba08-e0a5137ce9aa.pdf",
            "news_date": "2025-07-17 16:57:26"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Business Responsibility and Sustainability Reporting (BRSR)",
            "caption": "Business Responsibility and Sustainability Reporting (BRSR)",
            "news_body": "Business Responsibility and Sustainability Reporting for the FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5017ff3b-3b1f-4e40-8504-66f6b3a3c4f0.pdf",
            "news_date": "2025-07-15 19:03:50"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Reg. 34 (1) Annual Report",
            "caption": "Reg. 34 (1) Annual Report.",
            "news_body": "Annual report of Mankind Pharma Limited for FY 2024-25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f4249a79-2986-44b0-b7d4-a24ec3409ba9.pdf",
            "news_date": "2025-07-15 18:59:08"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Notice Of 34Th Annual General Meeting Of Mankind Pharma Limited",
            "news_body": "Please find attached Notice of 34th Annual General Meeting of Mankind Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=102814cd-75fb-49ed-a202-f17392e73592.pdf",
            "news_date": "2025-07-15 18:40:42"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "In continuation of our earlier letter dated June 26 2025 under subject Closure of Trading Window under SEBI (Prohibition of Insider Trading ) Regulations 2015 and Companys Code of Conduct for Prevention of Insider Trading the trading window for trading in the securities of the Company shall remain close till August 2 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3f712fd8-e7bf-4e60-81a5-a30da6334ba7.pdf",
            "news_date": "2025-07-14 22:10:43"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Dividend",
            "caption": "Corporate Action-Board to consider Dividend",
            "news_body": "The Board of Directors of the Company in its meeting scheduled to be held on July 31 2025 may consider and declare interim dividend for FY 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4672164d-82aa-46b3-9d3c-63aba8ff8600.pdf",
            "news_date": "2025-07-14 22:02:18"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Board Meeting",
            "caption": "Board Meeting Intimation for Unaudited Quarterly Financial Results & Interim Dividend",
            "news_body": "Mankind Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2025 inter alia to consider and approve Pursuant to Regulation 29 & 50 of the Listing Regulations we wish to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Thursday July 31 2025 inter-alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter ended on June 30 2025; and declaration of interim dividend if any for the financial year 2025-26.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1ec5b250-0d0e-44ba-b0dc-1385bde8d81b.pdf",
            "news_date": "2025-07-14 21:58:44"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
            "news_body": "Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=995a0377-ae98-4022-99a4-72a7acaef6e1.pdf",
            "news_date": "2025-07-04 15:42:06"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper advertisement for information regarding the 34th Annual General Meeting of Mankind Pharma Limited",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f1c6a732-715f-4a50-a07b-547636369c63.pdf",
            "news_date": "2025-07-04 12:43:08"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "AGM",
            "caption": "Intimation Of The Date Of 34Th Annual General Meeting (AGM) Of The Company",
            "news_body": "Intimation of the date of 34th AGM of the Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8e9c22b2-a1e6-427b-9200-091d76e23b63.pdf",
            "news_date": "2025-07-03 15:40:35"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Intimation",
            "descriptor": "Closure of Trading Window",
            "caption": "Closure of Trading Window",
            "news_body": "Closure of Trading Window",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d79fed28-423b-4b7e-b24e-c85de49d90e6.pdf",
            "news_date": "2025-06-26 16:27:24"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of participation in the Investor Conferences",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=125f75b9-3847-4b5a-b906-29cb176053db.pdf",
            "news_date": "2025-06-16 12:53:44"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of 57709 Equity Shares under Mankind Employee Stock Option Plan 2022",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4f8dd731-59f0-46f4-8c48-4787328e5cee.pdf",
            "news_date": "2025-06-10 10:47:29"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulations 30 & 51 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Environmental Social And\r\nGovernance (ESG) Rating",
            "news_body": "Intimation under Regulation30 & 51 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Environmental Social and Governance Rating",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=31da8f63-6141-4362-b44a-eacd714d0325.pdf",
            "news_date": "2025-06-04 23:34:31"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Intimation of incorporation of KINDCARE FOUNDATION a Wholly Owned Subsidiary Company",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9d39d486-3bbf-4c51-a806-782c7913d854.pdf",
            "news_date": "2025-06-02 19:00:55"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q4 & FY25 - Transcript",
            "news_id": "af8061e8-6a3f-499e-9038-3359da4d21e3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6d2d808-2fb6-4350-a73a-0df90d043dfa.pdf",
            "news_date": "2025-05-27 15:11:34",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Earnings Call Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q4 & FY25 - Transcript",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b6d2d808-2fb6-4350-a73a-0df90d043dfa.pdf",
            "news_date": "2025-05-27 15:11:34"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of participation in the Investor Conferences",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48c55e70-443a-4111-8b2b-088497597a13.pdf",
            "news_date": "2025-05-27 09:43:32"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
            "news_body": "Intimation of participation in the Investor Conferences",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5febf353-9add-423b-86cb-7b291d11c187.pdf",
            "news_date": "2025-05-22 12:52:44"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Newspaper Publication",
            "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
            "news_body": "Newspaper Publication of Audited Financial Results of the Company for the quarter and financial year ended on March 31 2025.",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f17eb0bf-33c3-4c29-9456-94e2a4cf806c.pdf",
            "news_date": "2025-05-22 12:38:03"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q4 & FY25 - Audio Recording",
            "news_id": "8c4a4b4c-8825-4e75-8d5b-80c32c841d6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16d5125f-cd4f-45b9-bb3a-65674a6c0eaf.pdf",
            "news_date": "2025-05-21 20:39:34",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Analyst / Investor Meet",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q4 & FY25 - Audio Recording",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=16d5125f-cd4f-45b9-bb3a-65674a6c0eaf.pdf",
            "news_date": "2025-05-21 20:39:34"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Appointment Of Cost Auditor And Secretarial Auditor",
            "news_body": "Appointment of Cost Auditor and Secretarial Auditor",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=752b7aac-e1c2-49a1-a40c-e224f6780b0a.pdf",
            "news_date": "2025-05-21 18:32:07"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Acquisition",
            "caption": "Announcement under Regulation 30 (LODR)-Acquisition",
            "news_body": "Incorporation of WOS directly or indirectly in Sri Lanka",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0071597-b82d-4013-a290-ec3be22a4f2b.pdf",
            "news_date": "2025-05-21 18:25:17"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "65107d92-cb35-4fc1-a026-1b3f07b97111",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4d04fa-6dcd-4aa0-aab0-8add14647615.pdf",
            "news_date": "2025-05-21 18:19:25",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf4d04fa-6dcd-4aa0-aab0-8add14647615.pdf",
            "news_date": "2025-05-21 18:19:25"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q4FY25",
            "news_id": "e2b781e1-0008-446b-b77a-62686fd294d6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e768a11-e3f8-46fe-be52-d95b8ea90c41.pdf",
            "news_date": "2025-05-21 18:07:53",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q4FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6e768a11-e3f8-46fe-be52-d95b8ea90c41.pdf",
            "news_date": "2025-05-21 18:07:53"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Press Release / Media Release",
            "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
            "news_body": "Press Release - Q4FY25",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=edfa45e1-743a-44b8-93b9-63f1f7c80b00.pdf",
            "news_date": "2025-05-21 18:06:38"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "news_id": "1f8b4f14-67ca-4305-97ee-a68dc314b23c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5caf3035-d446-4f0b-9125-65393dca8fd5.pdf",
            "news_date": "2025-05-21 18:05:07",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "Outcome",
            "descriptor": "Financial Results",
            "caption": "Outcome Of Board Meeting",
            "news_body": "Outcome of Board Meeting",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5caf3035-d446-4f0b-9125-65393dca8fd5.pdf",
            "news_date": "2025-05-21 18:05:07"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "Allotment of ESOP / ESPS",
            "caption": "Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS",
            "news_body": "Allotment of 92512 Equity shares under Mankind Employee Stock Option Plan 2022",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7239f461-cd87-4883-ab39-604f6113a088.pdf",
            "news_date": "2025-05-21 10:46:01"
        },
        {
            "co_code": 38451,
            "bse_code": 543904,
            "isin": "INE634S01028",
            "ann_type": "General_Announcements",
            "descriptor": "General",
            "caption": "Intimation Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
            "news_body": "Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=efe14610-e518-4a50-8332-42846ee01f83.pdf",
            "news_date": "2025-05-15 17:51:28"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q3 & 9M FY25 - Transcript",
            "news_id": "6cc0b2ec-a7f0-4dfd-ba54-9ebd94598852",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=09cab4ef-bf88-40b1-be1e-cabdff929690.pdf",
            "news_date": "2025-01-30 15:12:00",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for Q3FY25",
            "news_id": "16360e86-20bf-428b-832b-4b8fd6232522",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8f508c34-1b16-40d2-b8e9-55cea708bdcf.pdf",
            "news_date": "2025-01-23 19:54:20",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q2 & H1FY25 - Transcript",
            "news_id": "054f2d2d-e42b-4caf-81ea-ff803e2b716e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1fde1a79-c646-4353-b99b-69b0f12d9383.pdf",
            "news_date": "2024-11-11 18:20:53",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q2 & H1 FY25 - Audio Recording",
            "news_id": "24fcfee7-0b76-406b-ab81-ae8064e4317a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=223ff998-8c61-443b-9f60-c34f38769011.pdf",
            "news_date": "2024-11-05 21:43:47",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation  for Q2FY25",
            "news_id": "3db4cba1-36ec-4b13-a811-9734529d94bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf840817-d664-47d4-858e-990b6fa71162.pdf",
            "news_date": "2024-11-05 16:39:56",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. November 5, 2024",
            "news_body": "Outcome of Board Meeting held today i.e. November 5, 2024",
            "news_id": "bd998fce-4dc8-4d49-9731-c4f172bfc147",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a35920d7-fea8-49a2-abe8-1d28afb26b80.pdf",
            "news_date": "2024-11-05 16:30:05",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation for the information of Investors",
            "news_id": "f6bd3b9e-9669-4a28-93bc-ed6d5cddad7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=87dce799-cad1-4805-8128-4d819376836c.pdf",
            "news_date": "2024-09-02 17:31:37",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation at 20th Annual Global Investor Conference Organized by Motilal Ostwal",
            "news_id": "6a04c5c7-4c19-4c2a-8d03-d88fa717aea2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48686b39-01f2-4ab2-a614-0378c6d56f6c.pdf",
            "news_date": "2024-08-20 07:29:52",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation at 20th Annual Global Investor Conference Organized by Motilal Ostwal",
            "news_id": "82dd5323-a128-42b8-be09-79b630c58d21",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ed70faa4-fc89-4b4a-a787-b72ae2e67a98.pdf",
            "news_date": "2024-08-20 07:28:28",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q1FY25- Transcript",
            "news_id": "ebbed0e6-1896-4614-b395-086ee9b1acb4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8d30e4d4-4e89-464c-bc32-91c670ef6391.pdf",
            "news_date": "2024-08-06 18:04:44",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q1FY25- Audio Recording",
            "news_id": "49b5f028-159a-4c32-9c1c-bc3d8f7c1ec4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ff718367-b61a-4cb7-9ace-d0914d6b48ff.pdf",
            "news_date": "2024-07-31 20:47:02",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results of the Company for the quarter ended on June 30, 2024.",
            "news_id": "bb963b8e-4c4e-4a61-bd15-d756891d3689",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=442aa76b-b1ba-4c21-ba47-2eab3db99062.pdf",
            "news_date": "2024-07-31 15:02:41",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. July 31, 2024",
            "news_body": "Outcome of Board Meeting- Financial Results for the quarter ended June 30, 2024.",
            "news_id": "6ea6c394-a451-4dc8-bb22-b8009a87be69",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=416167a9-edcf-4b2f-a6a5-39f8728d1708.pdf",
            "news_date": "2024-07-31 14:47:04",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Audio Recording of Conference Call held on July 26, 2024 at 05:00 p.m. in relation to acquisition of 100% stake in Bharat Serums and Vaccines Limited",
            "news_id": "72592a98-774d-4bc8-8d73-8649c6c6c5b8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8c181d00-75e8-4295-9156-0ba481f74f91.pdf",
            "news_date": "2024-07-27 13:42:47",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Mankind Pharma to acquire 100% stake in BSV",
            "news_id": "629a529e-d399-4e5b-9fcf-62c18c1fae7b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bee6639e-6050-4df2-a8d1-e1fcb6cfd5a5.pdf",
            "news_date": "2024-07-25 22:09:38",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q4FY24 - Transcript",
            "news_id": "a9747884-846f-4aaf-ae3e-e65d0a29223c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7a58344-29d8-4a71-baac-2e6db4d892a0.pdf",
            "news_date": "2024-05-22 14:45:53",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q4FY24 - Audio Recording",
            "news_id": "71aa8510-250c-4591-9420-d3539dac5865",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4bcb9ac8-2211-4578-ad64-c0cf0fb796e4.pdf",
            "news_date": "2024-05-16 18:41:20",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the quarter and financial year ended 31st March 2024.",
            "news_id": "47a6a321-cd3e-4fa1-8abe-c130016ef737",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=06376baa-a3ae-4608-91d0-4d6cf3af34f2.pdf",
            "news_date": "2024-05-15 19:41:20",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations').",
            "news_body": "Outcome of Board Meeting held today i.e. May 15, 2024",
            "news_id": "d3f9aebb-8193-4869-8fb3-103dccf6f168",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d053d67-d33e-4e84-b6fa-60c29bb40f08.pdf",
            "news_date": "2024-05-15 18:17:57",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Investor Conference Call for Q3 FY24 - Transcript",
            "news_id": "02d53c7a-7631-45ee-ac0e-811b2694e58d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3f32017-1f45-48a7-aa5f-6c6150aa31cf.pdf",
            "news_date": "2024-02-07 15:33:09",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q3 FY24- Audio Recording",
            "news_id": "4cef3a76-2a30-49e2-843a-3f471184029f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a6a6e888-3537-46c2-9caa-7385bffb91f3.pdf",
            "news_date": "2024-02-02 16:11:02",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results of Q3 FY24",
            "news_id": "2062e94b-1947-436e-aaa0-894747ef3e33",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ede6ee85-f8f2-4dc5-bce7-52cffbfd1659.pdf",
            "news_date": "2024-01-31 18:02:22",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. January 31, 2024",
            "news_body": "Outcome of Board Meeting held today i.e. January 31, 2024",
            "news_id": "2ae04ca0-1d86-43ce-921d-a5248a913cf1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=562a670e-210b-4cf0-84e3-26508413336b.pdf",
            "news_date": "2024-01-31 17:32:48",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Presentation at 42nd Annual JP Morgan Healthcare Conference",
            "news_id": "c298a854-16f1-4b3a-9546-4dd98ecf9e27",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e62dd2c-fead-4e24-81f3-ec34f72b8f7f.pdf",
            "news_date": "2024-01-10 19:00:49",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, please find attached the transcript of the Investor Conference Call for Q2FY24 held on November 01, 2023.",
            "news_id": "2314bd8f-79f1-46c3-9adf-a01fd1e1473a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=dbb2a66f-ad87-4ce6-9a07-70740af925ec.pdf",
            "news_date": "2023-11-07 16:58:38",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Investor Conference Call for Q2FY24 - Audio Recording",
            "news_id": "b8d4978c-a6a4-49e6-8709-876c1c920003",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0018f7ae-b389-45aa-bde6-ac796dffcfca.pdf",
            "news_date": "2023-11-01 16:30:08",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation on Financial Results of Q2FY23-24",
            "news_id": "62d04440-5313-4d7c-872d-cc11ab9079c7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=02982d5d-b2ce-4cf2-a89d-f2bb6365c23e.pdf",
            "news_date": "2023-10-31 18:00:23",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Outcome Of Board Meeting Held Today I.E. October 31, 2023",
            "news_body": "Outcome of Board Meeting held today i.e. October 31, 2023",
            "news_id": "b31ff714-199b-4893-bfff-550bfea4a66e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eb68c5cc-6e38-4d6a-905e-d3ef9e57a4bf.pdf",
            "news_date": "2023-10-31 17:26:03",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Investor Conference Call for Q1FY24 held on Thursday, August 03, 2023.",
            "news_id": "cd9abc52-5a14-42e5-974f-ad0a1bd6b000",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99cd547d-ee26-4dfe-b779-872eac23421a.pdf",
            "news_date": "2023-08-08 13:57:11",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated July 21, 2023 under subject 'Intimation of Investor Conference Call on Q1FY24 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 03rd August 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230803148085-orignal-1691059985.mp3",
            "news_id": "2b7ae713-5d1c-468b-b8b0-7752996defde",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1d8e5e05-8e03-42d2-a351-c07cd84fc0a4.pdf",
            "news_date": "2023-08-03 17:40:33",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation of Q1FY2023-24",
            "news_id": "f2fea323-586e-4524-a24b-e33f297525c3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42cc1661-75a1-44d4-97f9-ee49553d5d1e.pdf",
            "news_date": "2023-08-02 18:54:19",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. August 2, 2023",
            "news_body": "Outcome of Board Meeting as per letter attached",
            "news_id": "1cdf29f5-7601-4bd0-a059-a5a7a2135e4c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b75992a8-081a-4824-bcb7-9004650c7993.pdf",
            "news_date": "2023-08-02 18:16:36",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Regulation 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015",
            "news_body": "Outcome of Board Meeting as per letter attached.",
            "news_id": "b8bcde9c-c284-4563-b68d-666ca474ecf2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=886f507b-ab33-4fbe-85c3-de279bfdbdc6.pdf",
            "news_date": "2023-08-02 18:11:30",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the Performance and Business Update Call for Q4FY23 & FY23 held on Wednesday, 31st May 2023. The transcript is also available on the website of the Company at https://www.mankindpharma.com/media/investor/q4-fy23-transcript-1686050139.pdf",
            "news_id": "e55f420c-b40a-4051-aff6-514a856cd8de",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8a92a5d-2a2f-4be4-9fac-e3c66611afc5.pdf",
            "news_date": "2023-06-06 18:15:10",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and further to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY23 with Senior Management of Mankind Pharma Limited', the audio recording of the Performance and Business Update Call held today i.e. 31st May 2023 is available on the website of the Company at https://www.mankindpharma.com/media/investor/kot1320230531147437-1685528185.mp3",
            "news_id": "2e855c47-e439-42d0-8739-ca4795a24ce8",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c83cf737-2a82-4ade-9639-28a4a3d3618d.pdf",
            "news_date": "2023-05-31 18:37:39",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "In reference to our intimation dated 25th May 2023 under subject 'Intimation of Performance and Business Update Call on Q4FY23 & FY 23 with Senior Management of Mankind Pharma Limited ('the Company')' and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the presentation that would be placed in a Performance and Business update call for Q4FY23 & FY 23 scheduled on Wednesday, 31st May 2023 at 12 noon (IST).The presentation is also being uploaded on the website of the company i.e. www.mankindpharma.com.",
            "news_id": "688a75a3-ca1a-45b1-bdef-311882eac6c5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5c22100a-da67-4b8b-a47a-b88966354716.pdf",
            "news_date": "2023-05-30 19:31:02",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "MANKIND",
            "disp": "Mankind Pharma",
            "bse_code": 543904,
            "isin": "INE634S01028",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Audited Standalone And Consolidated Financial Results Of The Company For The Quarter And Financial Year Ended On 31St March 2023",
            "news_body": "We are enclosing herewith as follows:a. Audited Standalone and Consolidated Financial Results of the Company for the quarter and financial year ended on 31st March 2023; b. Auditors' report with unmodified opinion on the audited Standalone and Consolidated Financial Results of the Company for the financial year ended on 31st March 2023; and c. The declaration from Chief Financial Officer pursuant to Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements), 2015, Regulations confirming the unmodified opinion of the statutory auditors on the audited Standalone and Consolidated Financial Results of the Company for the financial year ended on 31st March 2023.The meeting of Board of Directors of the Company commenced at 05:05 p.m. (IST) and concluded at 06:45 p.m.The above mentioned documents will also be available on the website of the Company at www.mankindpharma.com.",
            "news_id": "d6a79006-f11c-4eb6-90ee-e83359bdfd72",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1cafe8db-068a-4fad-bf10-73f683a5b350.pdf",
            "news_date": "2023-05-30 18:59:15",
            "seo": "mankind-pharma-ltd",
            "ltp": 2087,
            "ch": 13.900000000000091,
            "pch": 0.6704934638946549,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 15380,
            "exch": "NSE",
            "seg": "E"
        }
    ]
}